Therapeutic efficacy of anti-ErbB2 immunoliposomes targeted by a phage antibody selected for cellular endocytosis

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1591, Issue 1-3, 2002, Pages 109-118

  Nielsen, Ulrik B ^a   Kirpotin, Dmitri B ^b   Pickering, Edward M ^a   Hong, Keelung ^b   Park, John W ^c   Refaat Shalaby, M ^b   Shao, Yi ^b   Benz, Christopher C ^c   Marks, James D ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

ErbB2; Immunoliposome; Immunotherapy; Phage antibody library; Receptor mediated endocytosis; scFv; Single chain Fv; Tumor targeting

Indexed keywords

ANTIBODY; CYSTEINE; DOXORUBICIN; IMMUNOLIPOSOME; IMMUNOMODULATING AGENT; LIPOSOME; NANOPARTICLE; RECEPTOR;

ANALYTIC METHOD; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER CELL; CARBOXY TERMINAL SEQUENCE; CELL LINE; CONTROLLED STUDY; CYTOPLASM; DRUG MECHANISM; ENDOCYTOSIS; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IMMUNOTHERAPY; LIBRARY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; SURFACE PLASMON RESONANCE; TARGET CELL; TUMOR CELL; TUMOR VOLUME; XENOGRAFT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIBODIES; DISEASE MODELS, ANIMAL; DOXORUBICIN; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; ENDOSOMES; FEMALE; KINETICS; LIPOSOMES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RECEPTOR, ERBB-2; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ESCHERICHIA COLI;

EID: 0037135703     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(02)00256-2     Document Type: Article

References (50)

1. Altenschmidt U., Schmidt M., Groner B., Wels W. Int. J. Cancer. 73:1997;117-124.
2. Kirpotin D., Park J.W., Hong K., Zalipsky S., Li W.L., Carter P., Benz C.C., Papahadjopoulos D. Biochemistry. 36:1997;66-75.
3. Fominaya J., Wels W. J. Biol. Chem. 271:1996;10560-10568.
4. Marks J.D., Hoogenboom H.R., Bonnert T.P., McCafferty J., Griffiths A.D., Winter G. J. Mol. Biol. 222:1991;581-597.
5. Hurwitz E., Stancovski I., Sela M., Yarden Y. Proc. Natl. Acad. Sci. U. S. A. 92:1995;3353-3357.
6. Yarden Y. Proc. Natl. Acad. Sci. U. S. A. 87:1990;2569-2573.
7. Becerril B., Poul M.A., Marks J.D. Biochem. Biophys. Res. Commun. 255:1999;386-393.
8. Sheets M.D., Amersdorfer P., Finnern R., Sargent P., Lindqvist E., Schier R., Hemingsen G., Wong C., Gerhart J.C., Marks J.D. Proc. Natl. Acad. Sci. U. S. A. 95:1998;6157-6162.
9. Poul M.A., Becerril B., Nielsen U.B., Morisson P., Marks J.D. J. Mol. Biol. 301:2000;1149-1161.
10. Schier R., Marks J.D., Wolf E.J., Apell G., Wong C., McCartney J.E., Bookman M.A., Huston J.S., Houston L.L., Weiner L.M.et al. Immunotechnology. 1:1995;73-81.
11. Schier R., McCall A., Adams G.P., Marshall K.W., Merritt H., Yim M., Crawford R.S., Weiner L.M., Marks C., Marks J.D. J. Mol. Biol. 263:1996;551-567.
12. Carter P., Kelley R.F., Rodrigues M.L., Snedecor B., Covarrubias M., Velligan M.D., Wong W.L., Rowland A.M., Kotts C.E., Carver M.E.et al. Biotechnology (NY). 10:1992;163-167.
13. Straubinger R.M., Papahadjopoulos D., Hong K.L. Biochemistry. 29:1990;4929-4939.
14. Williams S.S., Alosco T.R., Mayhew E., Lasic D.D., Martin F.J., Bankert R.B. Cancer Res. 53:1993;3964-3967.
15. Vaage J., Mayhew E., Lasic D., Martin F. Int. J. Cancer. 51:1992;942-948.
16. Morrison W.R. Anal. Biochem. 7:1964;221-224.
17. Benz C.C., Scott G.K., Sarup J.C., Johnson R.M., Tripathy D., Coronado E., Shepard H.M., Osborne C.K. Breast Cancer Res. Treat. 24:1993;85-95.
18. Nielsen U.B., Adams G.P., Weiner L.M., Marks J.D. Cancer Res. 60:2000;6434-6440.
19. Pinilla C., Buencamino J., Appel J.R., Hopp T.P., Houghten R.A. Mol. Divers. 1:1995;21-28.
20. Daleke D.L., Hong K., Papahadjopoulos D. Biochim. Biophys. Acta. 1024:1990;352-366.
21. Lewis G.D., Figari I., Fendly B., Wong W.L., Carter P., Gorman C., Shepard H.M. Cancer Immunol. Immunother. 37:1993;255-263.
22. Baselga J., Norton L., Albanell J., Kim Y.M., Mendelsohn J. Cancer Res. 58:1998;2825-2831.
23. Akerström B., Nilson B.H., Hoogenboom H.R., Björck L. J. Immunol. Methods. 177:1994;151-163.
24. Park J.W., Hong K., Kirpotin D.B., Meyer O., Papahadjopoulos D., Benz C.C. Cancer Lett. 118:1997;153-160.
25. Park J.W., Hong K., Kirpotin D.B., Colbern G., Shalaby R., Baselga J., Shao Y., Nielsen U.B., Marks J.D., Moore D., Papahadjopoulos D., Benz C.C. Clin. Cancer Res. 8:2002;1172-1181.
26. Ishida T., Iden D.L., Allen T.M. FEBS Lett. 460:1999;129-133.
27. Karlsson R., Fagerstam L., Nilshans H., Persson B. J. Immunol. Methods. 166:1993;75-84.
28. Craig L., Sanschagrin P.C., Rozek A., Lackie S., Kuhn L.A., Scott J.K. J. Mol. Biol. 281:1998;183-201.
29. Maruyama K., Takizawa T., Yuda T., Kennel S.J., Huang L., Iwatsuru M. Biochim. Biophys. Acta. 1234:1995;74-80.
30. Scott G.K., Robles R., Park J.W., Montgomery P.A., Daniel J., Holmes W.E., Lee J., Keller G.A., Li W.L., Fendly B.M.et al. Mol. Cell. Biol. 13:1993;2247-2257.
31. Vidal M., Sainte-Marie J., Philippot J.R., Bienvenue A. FEBS Lett. 216:1987;159-163.
32. van Slooten H.J., Bonsing B.A., Hiller A.J., Colbern G.T., van Dierendonck J.H., Cornelisse C.J., Smith H.S. Br. J. Cancer. 72:1995;22-30.
33. Nielsen U.B., Marks J.D. Pharm. Sci. Technol. Today. 2000;282-291.
34. Press O.W., Martin P.J., Thorpe P.E., Vitetta E.S. J. Immunol. 141:1988;4410-4417.
35. Xu F., Lupu R., Rodriguez G.C., Whitaker R.S., Boente M.P., Berchuck A., Yu Y., DeSombre K.A., Boyer C.M., Bast R.C.J. Int. J. Cancer. 53:1993;401-408.
36. Révillion F., Bonneterre J., Peyrat J.P. Eur. J. Cancer. 34:1998;791-808.
37. Drummond D.C., Meyer O., Hong K., Kirpotin D.B., Papahadjopoulos D. Pharmacol. Rev. 51:1999;691-743.
38. Papahadjopoulos D., Allen T.M., Gabizon A., Mayhew E., Matthay K., Huang S.K., Lee K.D., Woodle M.C., Lasic D.D., Redemann C.et al. Proc. Natl. Acad. Sci. U. S. A. 88:1991;11460-11464.
39. Huang S.K., Mayhew E., Gilani S., Lasic D.D., Martin F.J., Papahadjopoulos D. Cancer Res. 52:1992;6774-6781.
40. Horowitz A.T., Barenholz Y., Gabizon A.A. Biochim. Biophys. Acta. 1109:1992;203-209.
41. Park J.W., Hong K., Carter P., Asgari H., Guo L.Y., Keller G.A., Wirth C., Shalaby R., Kotts C., Wood W.I.et al. Proc. Natl. Acad. Sci. U. S. A. 92:1995;1327-1331.
42. Goren D., Horowitz A.T., Zalipsky S., Woodle M.C., Yarden Y., Gabizon A. Br. J. Cancer. 74:1996;1749-1756.
43. Berinstein N., Matthay K.K., Papahadjopoulos D., Levy R., Sikic B.I. Cancer Res. 47:1987;5954-5959.
44. Machy P., Pierres M., Barbet J., Leserman L.D. J. Immunol. 129:1982;2098-2102.
45. Matthay K.K., Abai A.M., Cobb S., Hong K., Papahadjopoulos D., Straubinger R.M. Cancer Res. 49:1989;4879-4886.
46. Hansen C.B., Kao G.Y., Moase E.H., Zalipsky S., Allen T.M. Biochim. Biophys. Acta. 1239:1995;133-144.
47. Allen T.M., Ahmad I., Lopes de Menezes D.E., Moase E.H. Biochem. Soc. Trans. 23:1995;1073-1079.
48. Harding J.A., Engbers C.M., Newman M.S., Goldstein N.I., Zalipsky S. Biochim. Biophys. Acta. 1327:1997;181-192.
49. Neve R.M., Nielsen U.B., Kirpotin D.B., Poul M.A., Marks J.D., Benz C.C. Biochem. Biophys. Res. Commun. 280:2001;274-279.
50. Ewer M.S., Gibbs H.R., Swafford J., Benjamin R.S. Semin. Oncol. 26:1999;96-101.